G/TBT/N/PHL/239  
25 August 2020  
(20-5808) Page: 1/2 
Committee on Technical Barriers to Trade  Original:  English  
 
  
NOTIFICATION  
The following notification is being circulated in accordance with Article 10.6  
 
1. Notifying Member:  PHILIPPINES   
If applicable, name of local government involved (Article 3.2 and 7.2):   
2. Agency responsible:   
ENGR. ANA TRINIDAD F. RIVERA  
Director IV  
Center for Cosmetics Regulation and Research (CCRR)  
Food and Drug Administration  
DEPARTMENT OF HEALTH  
Name and address (including telephone and fax numbers , email and website 
addresses, if available) of agency o r authority designated to handle comments 
regarding the notification shall be indicated if different from above:   
MR. JEKEE BRYAN T. MIRAFLOR  
Center for Cosmetics Regulation and Research (CCRR)  
Food and Drug Administration  
DEPARTMENT OF HEALTH  
Email: jbtmiraflor@fda.gov.ph ; atfrivera@fda.gov.ph  
www.fda.gov.ph   
3. Notified under Article 2.9.2 [X], 2.10.1 [   ], 5.6.2 [   ], 5.7.1 [   ], other :  
4. Products covered (HS or CCCN where applicable, otherwise national tariff 
heading. ICS numbers may be provided in addition, where applicable):  Vapor 
products; Tobacco, tobacco products and related equipment (ICS 65.160)  
5. Title, nu mber of pages and language(s) of the notified document:  Guidelines for 
the Issuance of Pre -application Documentary Evaluation (PADE) for Vapor Products 
Seeking Registration under FERN 1 with the Center for Cosmetics Regulation and Research 
(5 page(s), in E nglish)  
6. Description of content:  This Circular is being issued to provide supplemental procedures 
and guidelines for the issuance of a Pre -application Documentary   Evaluation (PADE) 
certificate as part of the requirements for vapor product refills and c artridges under FDA 
Electronic Registration Number Category (FERN1) authorization and shall apply to all 
manufacturers, traders and importers seeking to apply for a FERN 1 authorization of their 
vapor product refills and cartridges.   
7. Objective and rati onale, including the nature of urgent problems where 
applicable:  Protection of human health or safety; Reducing trade barriers and facilitating 
trade; Other  G/TBT/N/PHL/239  
 
- 2 - 
 
  8. Relevant documents:   
Republic Act No. 9711 - FDA Act of 2009  
Section II of Executive Order No. 106   
9. Proposed date of adoption:  This Circular shall take effect 15 days after publication in 
a newspaper of general  
circulation and the Office of National Administrative Register of the UP Law Center.  
Proposed date of entry into force:  This Circular shall take effect 15 days after 
publication in a newspaper of general  
circulation and the Office of National Administrative Register of the UP Law Center.  
10. Final date for comments:  60 days from notification  
11. Texts available from:  National enquiry point [X] or address, telephone and fax 
numbers and email and website addresses, if available , of other body:   
MR. NEIL P. CATAJAY  
Director  
Bureau of Philippine Standards  
Department of Trade and Industry  
3F Trade and Indus try Building  
361 Sen. Gil Puyat Avenue  
Makati City  
Philippines  
1200  
(632) 7751 4700; (632) 7751 4706  
bps@dti.gov.ph  
http://www.bps.dti.gov.ph  
https://members.wto.org/crnattachments/2020/TBT/PHL/20_5073_00_e.pdf